Weight loss injection for adults with obesity or overweight
Part of Hormones & metabolism clinical trials.
This study tests a new injectable medication to help adults with obesity or overweight who don't have diabetes lose weight. It involves a reduced-calorie diet and exercise plan, and may offer an effective treatment option for weight management.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 19 and 75 years old.
- Have a BMI of 30 or higher, or a BMI between 27 and 30 with a weight-related health issue like high blood pressure or high cholesterol.
- Have tried to lose weight with diet and exercise before, but not succeeded enough.
- Be willing to follow a reduced-calorie diet and exercise plan during the study.
- Not have diabetes.
- Not have had a significant weight change (more than 5 kg) in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational injection called HRS-4729 to see if it helps people with obesity lose weight. It may offer a new treatment option for those who have been trying to manage their weight with diet and exercise.
This trial tests an investigational injection called MWN109 to help adults with overweight or obesity lose weight. It is a phase 3 study, meaning it is being tested in a large group of people to see how well it works and if it is safe.
This study tests a new injected medicine that may help people with type 2 diabetes and overweight or obesity lose weight. The trial will see how well it works and if it is safe compared to a placebo.
This study tests a new medicine to help adults with obesity or overweight lose weight. It's for people who have had trouble losing weight in the past and don't have diabetes.
This study tests an investigational injection called UBT251 to help people who are overweight or obese lose weight. It may also improve related health issues like high blood pressure or fatty liver. The trial lasts for a period and includes regular check-ins with the study team.
This study tests an investigational injection called SYH2069 for weight loss in people who are obese but do not have diabetes. It aims to see if the drug is safe and helps reduce body weight.
Hear when a new Obesity &Amp; Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.